第 8 節 免疫製劑
Immunologic agents
- 8.1疫苗及免疫球蛋白 Vaccines and Immunoglobulins
- 8.2免疫調節劑 Immunomodulators
- 8.2.1Cyclosporin如 Sandimmun111/5/1
- 8.2.2Tacrolimus
- 8.2.3多發性硬化症治療藥品115/3/1
- 8.2.3.1Interferon beta-la如 Rebif、Aubagio、Tecfidera、Plegridy、Zeposia、Mavenclad115/3/1
- 8.2.3.2Interferon beta-1b如 Betaferon 8MIU106/10/1
- 8.2.3.3Glatiramer acetate如 Copaxone injection97/8/1
- 8.2.3.4Natalizumab如 Tysabri100/5/1
- 8.2.3.5Fingolimod如 Gilenya115/3/1
- 8.2.3.6Alemtuzumab如 Lemtrada108/7/1
- 8.2.3.7Siponimod如 Mayzent110/3/1
- 8.2.4Etanercept如 Enbrel、Humira、Simponi、Orencia、Actemra、Xeljanz、Cimzia、Taltz、Lumicef、Jyseleca、Cosentyx114/10/1
- 8.2.4.1Etanercept如 Enbrel、Humira、Actemra、Xeljanz、Cosentyx114/10/1
- 8.2.4.2Etanercept如 Enbrel、Humira、Simponi、Orencia、Actemra、Xeljanz、Olumiant、Tunex、Remicade、Smyraf、Rinvoq、Jyseleca114/9/1
- 8.2.4.3Adalimumab如 Humira、Enbrel、Simponi、Cosentyx、Remicade靜脈注射、Cimzia、Taltz、Rinvoq、Xeljanz、Lumicef、Bimzelx115/5/1
- 8.2.4.4Adalimumab如 Humira、Enbrel、Simponi、Stelara、Cosentyx、Taltz、Xeljanz、Cimzia、Lumicef、Tremfya、Rinvoq、Skyrizi、Bimzelx115/8/1
- 8.2.4.5Adalimumab如 Humira、Enbrel、Simponi、Cosentyx、Taltz、Xeljanz、Cimzia、Tremfya、Rinvoq、Lumicef、Skyrizi、Bimzelx115/5/1
- 8.2.4.6Etanercept如 Enbrel、Humira、Stelara、Cosentyx、Taltz、Tremfya、Lumicef、Skyrizi、Cimzia、Spevigo、Bimzelx115/5/1
- 8.2.4.7Adalimumab如 Humira、Remicade、Entyvio、Stelara、Skyrizi、Rinvoq114/9/1
- 8.2.4.8Abatacept靜脈注射劑如 Orencia IV111/2/1
- 8.2.4.9Golimumab如 Simponi、Humira、Entyvio、Remicade、Xeljanz、Stelara、Rinvoq114/9/1
- 8.2.4.10Adalimumab如 Humira109/9/1
- 8.2.4.11Guselkumab如 Tremfya111/9/1
- 8.2.4.12Tocilizumab如 Actemra113/1/1
- 8.2.4.13Baricitinib (Olumiant)113/1/1
- 8.2.4.14Secukinumab如 Cosentyx114/7/1
- 8.2.5Leflunomide如 Arava、Arheuma97/9/1
- 8.2.6短效干擾素、長效干擾素
- 8.2.7Rituximab注射劑如 Mabthera109/11/1
- 8.2.8Palivizumab如 Synagis114/6/1
- 8.2.9Thalidomide如 Thado100/2/1
- 8.2.10Eculizumab如 Soliris、Ultomiris、Piasky115/3/1
- 8.2.11Plerixafor如 Mozobil106/10/1
- 8.2.12Canakinumab如 Ilaris104/8/1
- 8.2.13Belimumab如 Benlysta114/2/1
- 8.2.14Satralizumab如 Enspryng、Uplizna115/2/1
- 8.2.15Siltuximab如 Sylvant113/2/1
- 8.2.16Apremilast如 Otezla、Sotyktu114/6/1
- 8.2.17Mepolizumab如 Nucala、Fasenra115/4/1
- 8.2.18Anifrolumab如 Saphnelo113/10/1
- 8.2.19Danicopan如 Voydeya、Fabhalta115/9/1